Clinical Trials
30 results.
Part two: Before a new medication can be used in patients, it must go through a gauntlet of tests to ensure it is safe and effective
In the second installment in our multi-part series on how a new medication moves from the lab to the doctor’s office, we take a look…
Part one: How lab findings become life changing therapies
Here at VAI Voice, we often discuss topics related to basic research, translational medicine and clinical research. Today, in honor of National…
By Dr. Peter A. Jones and Dr. Steve Baylin Co-leaders, Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team Four years ago, we embarked…
A first-of-its-kind combination of medications may enable the immune system to better combat lung cancer, which claims more lives than any other cancer type and…
Nearly $5.5 million in grant funding to fuel collaborative clinical trials in lung and bladder cancers By Dr. Peter Jones and Dr. Steve Baylin Co-leaders,…
GRAND RAPIDS, Mich. (June 13, 2017)—A new clinical trial spanning three cancer centers in California, Maryland and Pennsylvania is investigating a promising…
GRAND RAPIDS, Mich. (May 15, 2017) — Stephen Baylin, M.D., Director’s Scholar and professor in the Center of Epigenetics at
Safety and efficacy of combining talazoparib with decitabine to treat acute myeloid leukemia (AML) are subject of multi-site clinical trial
GRAND RAPIDS, Mich. (March 7,…